Decision Resources Group (DRG), www.decisionresourcesgroup.com, a premier provider of high-value data, analytics and insights products and services to...
Could Microbiome-Based Therapies Upend The Asthma And COPD Markets?
Today, Healthcare Business Insights www.hbinsights.com (HBI), a part of Decision Resources Group www.decisionresourcesgroup.com (DRG), announced the...
A Cost-Utility Analysis Of Vertex's CF Drugs — What It Teaches Us About Trial Design
Lessons In Navigating The Increasingly Complex World Of Orphan Drug Commercialization
Spark's Luxturna Gene Therapy: What Can We Learn From Its Development & Commercialization?
